Status:
COMPLETED
Effect of Midazolam Premedication on Mask Ventilation Difficulty
Lead Sponsor:
Karaman Training and Research Hospital
Conditions:
Anesthesia Complication
Eligibility:
All Genders
2-10 years
Phase:
PHASE4
Brief Summary
Mask ventilation has great importance during anesthesia induction because it is the only way to oxygenate patients who have lost consciousness and spontaneous breathing. Adequate muscle relaxation and...
Detailed Description
American Society of Anesthesiologists (ASA) class I and II patients aged 2-10 years who are scheduled for any elective surgery under general anesthesia will be enrolled. Patients in midazolam group wi...
Eligibility Criteria
Inclusion
- age 2\< and \<10 children
- American Society of Anesthesiologists (ASA) class I and II
- Children who are scheduled for any elective surgery under general anesthesia
Exclusion
- age \<2 or \>10 years;
- obesity (body mass index, ≥35 kg/m2);
- craniofacial anomaly;
- allergic reaction to midazolam;
- presence of muscle weakness or dyspnea.
- children posted for any emergency procedure,
- above ASA class II
- children with abnormal airway anatomy,
- children with active respiratory infection in the last 3 weeks,
- children with a past history of chronic respiratory disorder,
- children who are being treated with sedative or anticonvulsive agents
Key Trial Info
Start Date :
May 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05368441
Start Date
May 24 2022
End Date
December 7 2022
Last Update
December 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karaman Training and Research Hospital
Karaman, Turkey (Türkiye)